Hydrochlorothiazide/atenolol/ramipril/simvastatin/aspirin - Cadila Pharmaceuticals

Drug Profile

Hydrochlorothiazide/atenolol/ramipril/simvastatin/aspirin - Cadila Pharmaceuticals

Alternative Names: Polycap; Polypill - Cadila Pharmaceuticals; Quintapill

Latest Information Update: 30 Jan 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Cadila Pharmaceuticals
  • Class Antihyperlipidaemics; Antihypertensives; Antiplatelets; Benzothiadiazines; Heterocyclic bicyclo compounds; Ischaemic heart disorder therapies; Naphthalenes; Propanolamines; Salicylates; Small molecules
  • Mechanism of Action ACE inhibitors; Beta 1 adrenergic receptor antagonists; Cyclooxygenase inhibitors; HMG-CoA reductase inhibitors; Platelet aggregation inhibitors; Thiazide diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Cardiovascular disorders; Coronary disorders; Stroke

Most Recent Events

  • 30 Jan 2014 Hydrochlorothiazide/atenolol/ramipril/simvastatin/aspirin - Cadila Pharmaceuticals is available for licensing in World as of 12 Apr 2009.
  • 30 Jan 2014 Launched for Cardiovascular disorders and Stroke (primary prevention) in India (PO) before January 2014
  • 01 Jun 2012 Phase-III clinical trials in Cardiovascular disorders (primary prevention) in India (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top